Clinical trials
Completed Carcinoma, Non-Small-Cell Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,779 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 58 |
| 2001 | 46 |
| 2002 | 70 |
| 2003 | 93 |
| 2004 | 106 |
| 2005 | 122 |
| 2006 | 145 |
| 2007 | 114 |
| 2008 | 147 |
| 2009 | 148 |
| 2010 | 113 |
| 2011 | 107 |
| 2012 | 103 |
| 2013 | 112 |
| 2014 | 106 |
| 2015 | 125 |
| 2016 | 145 |
| 2017 | 158 |
| 2018 | 152 |
| 2019 | 119 |
| 2020 | 107 |
| 2021 | 95 |
| 2022 | 64 |
| 2023 | 39 |
| 2024 | 34 |
| 2025 | 14 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2,779 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 108 |
| National Cancer Institute (NCI) | 99 |
| AstraZeneca | 93 |
| Hoffmann-La Roche | 66 |
| Pfizer | 64 |
| Alliance for Clinical Trials in Oncology | 53 |
| Boehringer Ingelheim | 51 |
| M.D. Anderson Cancer Center | 49 |
| Bristol-Myers Squibb | 46 |
| Memorial Sloan Kettering Cancer Center | 43 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 2,779 |
| Lung Neoplasms | 852 |
| Neoplasms | 211 |
| Breast Neoplasms | 183 |
| Small Cell Lung Carcinoma | 175 |
| Colorectal Neoplasms | 146 |
| Melanoma | 140 |
| Adenocarcinoma of Lung | 137 |
| Pancreatic Neoplasms | 124 |
| Neoplasm Metastasis | 123 |
Trials
Showing 1 to 25 of 2,779. Each trial links to its page on Pharma Observatory.
2,679 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.